LifeMD (LFMD) director awarded 22,365 RSs; holds 413,001 direct

LifeMD (LFMD) director John R. Strawn Jr. reported an award of 22,365 restricted shares of common stock on October 6, 2025 at a price of $0.

Rhea-AI Filing Summary

LifeMD (LFMD) director John R. Strawn Jr. reported an award of 22,365 restricted shares of common stock on October 6, 2025 at a price of $0. The filing states these restricted shares vest on June 1, 2026.

Following the grant, Strawn Jr. beneficially owned 413,001 shares directly and 60,000 shares indirectly through Strawn Pickens LLP.

Insider Trade Summary

Grant/Award: 22,365 shares

Grant/Award 2 txns

Insider Strawn John R Jr

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	22,365	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 413,001 shares (Direct); Common Stock — 60,000 shares (Indirect, Strawn Pickens LLP)

Footnotes (1)

1. F1. The grant of restricted shares vests on June 1, 2026.

FAQ

What insider transaction did LFMD disclose?

A director, John R. Strawn Jr., reported an award of 22,365 restricted shares at $0 on October 6, 2025.

When do the new LFMD restricted shares vest?

The filing states the restricted shares vest on June 1, 2026.

How many LFMD shares does the director own after the grant?

Following the grant, he beneficially owned 413,001 shares directly and 60,000 shares indirectly via Strawn Pickens LLP.

What was the price for the granted LFMD restricted shares?

The reported price for the restricted share grant was $0.

What is the role of the reporting person at LFMD?

John R. Strawn Jr. is a Director of LifeMD, Inc.

What form reported this LFMD insider activity?

The activity was reported on Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/08/2025 - 06:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Strawn John R Jr

(Last) (First) (Middle)

C/O LIFEMD, INC.

236 FIFTH AVENUE, 4TH FLOOR

(Street)

NEW YORK NY 10001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LifeMD, Inc. [ LFMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/06/2025		A		22,365(1)	A	$0	413,001	D
Common Stock								60,000	I	Strawn Pickens LLP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The grant of restricted shares vests on June 1, 2026.

	/s/ John R. Strawn Jr.	10/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.